Ensysce Biosciences Inc. (ENSC:NASDAQ) soared at $0.41, representing a gain of 22.3%. On Tue, Sep 13, 2022, ENSC:NASDAQ touched a New 2-Week Intraday High of $0.46. The stock appeared on our News Catalysts scanner on Thu, Sep 01, 2022 at 03:21 AM in the 'PATNERSHIP' category. From Tue, Aug 30, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Aug 17, 2022 at $0.75 with a volume of 12M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Akero Therapeutics, Inc. (AKRO:NASDAQ), 136.76%
- Aditxt Inc. (ADTX:NASDAQ), 113.75%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 101.04%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 79.32%
- 89bio, Inc. (ETNB:NASDAQ), 40%
- Motorsport Games Inc. (MSGM:NASDAQ), 28.14%
- Akouos Inc. (AKUS:NASDAQ), 28%
- Infobird Co. Ltd (IFBD:NASDAQ), 27.98%
- Golden Path Acquisition Corporation (GPCO:NASDAQ), 22.39%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 22.26%